Medical disclaimer: This content is for educational purposes only. It does not replace professional medical advice. Consult Dr. Kunal Waghray or your treating physician for diagnosis and treatment. Last reviewed May 2026 by Dr. Kunal Waghray, MD DM DNB MNAMS EDRM.
Malignant Pleural Effusion Treatment in Hyderabad
It is the third time in six weeks. The patient sits in the drainage suite, breathless again, watching a litre of straw-coloured fluid drain from around the lung. The family has stopped calling it an emergency. They have started treating it as a schedule.
The fluid came back ten days after the first procedure. Twelve days after the second. The question has shifted from “why is this happening” to something harder: “is there anything we can actually do about it?”
What malignant pleural effusion is, why the fluid keeps returning, and the two procedures that offer a more durable solution (an indwelling pleural catheter and pleurodesis) are all covered below in plain terms. This page is about quality of life, not cure. That distinction matters.
What Is Malignant Pleural Effusion and Why Does It Happen?
Fluid builds up in the pleural space — the thin gap between the lung and the chest wall — for many reasons. When the cause is cancer, the condition is called malignant pleural effusion (MPE). Cancer cells that have spread to the pleural lining disrupt the normal balance of fluid production and drainage, so fluid accumulates faster than the body can clear it.
This is different from ordinary pleural effusion caused by infection or heart failure. With benign effusions, treating the underlying cause often resolves the fluid. With MPE, the cancer cells are still present in the pleural space. They continue producing fluid regardless of how many times the area is drained.
In Indian oncology practice, the cancers most commonly associated with MPE are lung cancer, breast cancer, mesothelioma, and lymphoma. In any patient with a known cancer diagnosis who develops new breathlessness or chest heaviness, pleural effusion should be assessed early.
Why the Fluid Keeps Coming Back
Draining the fluid relieves breathlessness. It does not stop the fluid from returning. When cancer cells are present in the pleural lining, they irritate the surface and trigger the body to produce more fluid than it can absorb. Thoracentesis removes the accumulated fluid but leaves the underlying process untouched. Within days to weeks, the fluid begins to collect again.
Each repeat procedure carries its own risks: bleeding, infection, lung puncture, and, over time, scarring that makes future procedures more difficult. Repeated drainage is not neutral. It is a process that becomes harder to sustain and less effective with each cycle.
For patients whose fluid returns within two to three weeks, and for whom systemic therapy is not controlling the disease, repeated drainage has become the problem rather than the solution. Better options exist, and they are available in Hyderabad.
Three Options: Thoracentesis, IPC, and Pleurodesis
There are three ways to manage cancer-related pleural effusion. Each has a specific role, and the right choice depends on the individual patient's situation.
Thoracentesis (pleural tap)
Indwelling pleural catheter (IPC)
Pleurodesis
What Is a Trapped Lung, and Why It Matters
Not every lung can be re-inflated after fluid is drained. When it cannot, pleurodesis will not work. In some patients with cancer, the visceral pleura — the membrane that wraps around the lung itself — becomes thickened and rigid. When this membrane stiffens, the lung cannot expand outward to fill the chest cavity, even when the fluid around it has been removed.
Pleurodesis works by bringing the two pleural surfaces into direct contact and using a chemical agent to make them adhere permanently. Think of two pieces of fabric that need to be pressed together to bond. If one piece is stiff and cannot be pulled flat, the two surfaces will never fully meet. The bonding will not hold, and fluid will collect in the pockets that remain. This is why pleurodesis fails in trapped lung: not because the procedure was done incorrectly, but because the anatomy makes adhesion impossible.
In trapped lung, the indwelling pleural catheter is the correct management option. It allows ongoing drainage without requiring the lung to expand. A chest X-ray taken shortly after thoracentesis will show whether the lung has re-expanded to fill the space. If a significant gap remains, CT provides more detail about pleural thickening.
“When a patient with lung cancer has had three or four thoracentesis procedures and the fluid keeps coming back within two weeks, repeated drainage is no longer the right plan. The pleural space is never going to stop producing fluid as long as the tumour is there. An IPC lets the patient drain at home, on their schedule, and stay out of hospital. That is what quality of life means in this context.”
IPC vs Pleurodesis: How the Choice Is Made
The choice depends on three things: whether the lung can expand, how much time the patient has, and what matters most to them. There is no universal right answer. Both IPC and pleurodesis are well-evidenced approaches for cancer-related effusion. The decision is made by mapping the patient's clinical situation to the procedure that serves them best.
IPC is generally preferred when:
- •The lung is trapped and pleurodesis cannot work
- •Prognosis is measured in months; avoiding inpatient stays is a priority
- •The patient or family wants to manage drainage at home
- •A previous pleurodesis attempt has failed
- •Performance status is too low for a 2–4 day inpatient admission
Pleurodesis is generally preferred when:
- •Imaging confirms the lung expands fully after drainage
- •Reasonable prognosis; goal is a permanent one-time solution
- •Patient is fit enough for a short inpatient stay
- •Patient prefers to avoid managing a drain at home
What the clinical evidence shows
The AMPLE trial found that 87% of patients with cancer-related effusion reported symptom improvement at 12 weeks following IPC placement (PMCID PMC5502098). The TIME2 trial found that IPC patients spent a median of 10.0 days in hospital over the first twelve weeks, compared with 13.1 days for the pleurodesis group (PMCID PMC4878083). IPC patients spent meaningfully fewer days in hospital, which is a significant consideration for families already managing the demands of cancer treatment.
What to Expect at Respire Airway Clinics
IPC placement is done under local anaesthesia. Most patients go home the same day, within two hours of the procedure. Dr. Kunal Waghray trained in interventional pulmonology at Amrita Institute of Medical Sciences, Kochi, and performs IPC placement and pleurodesis as standard parts of his palliative pleural practice at Respire Airway Clinics, Hyderabad.
Before the patient leaves the clinic on the day of IPC placement, a member of the clinical team demonstrates how to connect the drainage bottle and drain at home. The patient and at least one family member are trained together. Most people are confident in the technique within one session. The clinic provides step-by-step written instructions and a direct contact number for questions.
For pleurodesis, the patient is admitted for two to four days. The procedure is performed via medical thoracoscopy or via an indwelling catheter, depending on anatomy and clinical preference. Talc is instilled to seal the pleural space. Chest discomfort in the first twenty-four to forty-eight hours is normal and is managed with analgesia.
Frequently Asked Questions
Is malignant pleural effusion treatable?
Yes, but the goal of treatment is quality of life rather than cure. No pleural drainage procedure treats the underlying cancer. What IPC and pleurodesis do is manage the fluid effectively: reducing breathlessness, allowing the patient to remain active, and reducing the number of hospital visits required. Both procedures are well-studied in patients with cancer-related effusion, and the evidence supports significant improvement in breathlessness and daily function for most patients who receive them.
Can I have an IPC while continuing chemotherapy or immunotherapy?
Yes. IPC placement does not interrupt cancer treatment. Many patients have their IPC placed while actively receiving chemotherapy, immunotherapy, or targeted therapy. Your oncologist and your interventional pulmonologist coordinate care to ensure timing does not conflict with treatment cycles. If systemic therapy eventually brings the cancer under control, the rate of fluid production may slow or stop, at which point the catheter can be assessed for removal.
How long does an IPC stay in place?
The catheter stays in place for as long as it is needed. In approximately 40 to 45 percent of patients, fluid production slows and eventually stops over time through a process called spontaneous pleurodesis. When drainage sessions consistently produce very little fluid, the team will assess whether the catheter can be removed. Some patients keep their IPC in place for several months; others for longer. The decision to remove it is based on fluid output, not a fixed time limit.
Is pleurodesis painful?
Pleurodesis causes chest discomfort and sometimes a sensation of tightness or burning in the hours after the procedure. This is expected and is managed with analgesia during the inpatient stay. The discomfort settles over one to two days in most patients. Talc, which is the agent used at Respire, is the most thoroughly studied sclerosant for MPE and is associated with good outcomes when the lung is confirmed to be expandable before the procedure.
What is the difference between an IPC and a standard chest drain?
A standard chest drain is placed in hospital for short-term drainage, typically over a few days, and then removed before the patient is discharged. It is not designed for home use. An indwelling pleural catheter is a tunnelled, long-term device designed to remain in place for weeks or months. It has a valve at the external end that can be opened and closed, allowing the patient to drain at home at scheduled intervals. The tunnelling under the skin reduces infection risk and holds the catheter in place without stitches.
Can pleurodesis be done if I already have an IPC in place?
In some cases, yes. If drainage sessions show that spontaneous pleurodesis has not occurred but imaging confirms the lung is expanding fully, a pleurodesis attempt can be considered while the IPC is in situ. The sclerosant is instilled through the catheter. Your interventional pulmonologist will review imaging before recommending this approach, as it is only appropriate when the anatomy supports it.
Do I need an interventional pulmonologist, or can a thoracic surgeon do this?
Both IPC placement and thoracoscopic pleurodesis can be performed by an interventional pulmonologist without the need for general anaesthesia or surgery. Dr. Kunal Waghray, MD DM DNB MNAMS EDRM, performs both procedures at Respire Airway Clinics in Hyderabad. A surgical referral is not required. If you have been advised that you need pleural intervention for cancer-related effusion, an interventional pulmonology consultation is the appropriate starting point.
Book a Consultation at Respire Airway Clinics
The family that began this page in the drainage suite, watching the fluid fill the bottle for the third or fourth time, deserved to know there was a different path. One procedure. Managed at home, on their schedule, without another hospital morning.
That path is available in Hyderabad. Book a consultation with Dr. Kunal Waghray at Respire Airway Clinics, Basheer Bagh or Jubilee Hills. All consultations are strictly confidential.
Clinical References
- AMPLE trial: indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion. JAMA. 2017. PMCID: PMC5502098.
- TIME2 trial: IPC vs talc pleurodesis — breathlessness and hospital days. JAMA. 2012. PMCID: PMC4878083.